Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Umang Pharmatech Pvt Ltd, is an unlisted private company incorporated on 18 May, 1992. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 2.84 cr.
Umang Pharmatech's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's book networth has decreased by 52.88%.
Read more
** All rupee values in INR lacs.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Renu Budhraja
Shareholder
|
01114263 | 34 years |
| Director | Umang Rajkumar Budhraja
Shareholder
|
08163388 | 7 years |
| Director | Payal Budhraja
Shareholder
|
10065964 | 3 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Syndicate Bank
No. of Loans: 1
Total Amount : 0.1 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| UMANG PARTICLE SCIENCE PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| UMANG ENCAPSULATION SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| EXCIPIENT GRANULES AND INGREDIENTS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| UMANG CONSUMER PRODUCTS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| UMANG GLOBAL GROUP PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| LABULTIMA PROCESS TECHNOLOGIES PRIVATE LIMITED |
Active
|
80.0 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Caleva Process Solutions Limited | - | - | - |
Read more
The incorporation date of UMANG PHARMATECH PVT LTD is 18 May, 1992
The authorized share capital of UMANG PHARMATECH PVT LTD is INR ₹ 10.0 Cr.
The paid-up capital of UMANG PHARMATECH PVT LTD is INR ₹ 2.8 Cr.
The registered address of UMANG PHARMATECH PVT LTD is Survey No 146, Hissa No 1pt Vasai Phata Palghar, Vasai East IE, Thane, Vasai, Maharashtra, India, 401208 - 401208
The CIN number of UMANG PHARMATECH PVT LTD is U29297MH1992PTC066815.